Stacy Wescoe//February 18, 2026//
On the heels of announcing a $3.5 billion investment by Eli Lilly to bring a pharmaceutical manufacturing facility to the Lehigh Valley, Gov. Josh Shapiro said the state has secured over $1 billion investment from Johnson & Johnson to build a next generation cell therapy manufacturing facility in Montgomery County.
Supported by a $41.5 million state investment, this expansion project will create more than 500 new jobs over the next twelve years and continue growing Pennsylvania’s robust life sciences industry. The project also helps retain 5,885 full-time jobs statewide.
PA Chamber President and CEO Luke Bernstein commented on the major investment.
“Johnson & Johnson’s announcement builds on recent momentum, including Eli Lilly’s $3.5 billion commitment in the Lehigh Valley, and reinforces that when Pennsylvania advances smart, pro-growth policies, employers respond with real investment,” Bernstein said.
Johnson & Johnson is constructing this state-of-the-art cell therapy manufacturing facility in Lower Gwynedd Township, Montgomery County. The facility will be operated by its subsidiary Janssen Biotech and will directly support the production of medicines for cancer, immune-mediated, and neurological diseases.
“Pennsylvania is a powerhouse for innovation and manufacturing in the life sciences,” said Governor Shapiro. “Just a few years ago we weren’t even on the field – but today we’re competing and winning. We’ve done it by creating the first economic development plan for Pennsylvania in two decades, and following through on it by cutting red tape, making strategic investments in key industries like the life sciences, and strengthening our workforce. That’s why companies like Johnson & Johnson are choosing to double down on their investments here in our Commonwealth – because they know we’ve got the strategy, the workforce, and the speed they need to succeed.”